Загрузка...
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells
The development of a prophylactic vaccine for hepatitis C virus (HCV) remains a global health challenge. Cumulative evidence supports the importance of antibodies targeting the HCV E2 envelope glycoprotein to facilitate viral clearance. However, a significant challenge for a B cell-based vaccine is...
Сохранить в:
| Опубликовано в: : | J Virol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430559/ https://ncbi.nlm.nih.gov/pubmed/30651366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01403-18 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|